Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients
-
* Corresponding author: Arne Simon asimon@ukb.uni-bonn.de
- Equal contributors
BMC Infectious Diseases 2008, 8:102 doi:10.1186/1471-2334-8-102
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 03 Feb 2008 | |
| Reviewer's Report | Michael Allon | 16 Feb 2008 | |
| Reviewer's Report | bart RIJNDERS | 31 Mar 2008 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 01 May 2008 |
| Reviewer's Report | Michael Allon | 12 May 2008 | |
| Reviewer's Report | bart RIJNDERS | 21 May 2008 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 14 Jul 2008 |
| Editorial acceptance | 23 Jul 2008 | ||
| Published | 29 Jul 2008 |